# Finerenone Therapy for Pediatric HSPN With Mild Proteinuria

> **NCT07315191** · PHASE4 · RECRUITING · sponsor: **Capital Institute of Pediatrics, China** · enrollment: 116 (estimated)

## Conditions studied

- Henoch Schönlein Purpura Nephritis

## Interventions

- **DRUG:** ACEI / ARB+finerenone
- **DRUG:** ACEI/ARB

## Key facts

- **NCT ID:** NCT07315191
- **Lead sponsor:** Capital Institute of Pediatrics, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-13
- **Primary completion:** 2027-10-31
- **Final completion:** 2028-04-30
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07315191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07315191, "Finerenone Therapy for Pediatric HSPN With Mild Proteinuria". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07315191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*